The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

National Cancer Screening Program for Hepatocellular Carcinoma

간암의 국가암검진사업

  • Kim, Jin-Wook (Department of Internal Medicine, Seoul National University College of Medicine)
  • 김진욱 (서울대학교 의과대학 내과학교실)
  • Published : 2013.05.01
⟨ Previous Next ⟩

Abstract

Surveillance of hepatocellular carcinoma has been implemented as a part of National Cancer Screening Program in Korea since 2003. The efficacy of the program in HCC screening is, however, to be validated yet. In this issue, Shim et al assessed the outcome of the program in a single-hospital based population, and showed that invitations for initial screening need to be modified to enhance the performance of the program.

Keywords

References

  1. Korean Liver Cancer Study Group and National Cancer Center, Korea. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol 2009;15: 391-423. https://doi.org/10.3350/kjhep.2009.15.3.391
  2. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: World Health Organization, 1968.
  3. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-422.
  4. World Health Organization. National Cancer Control Programmes: Policies and Managerial Guidelines. 2nd ed. Geneva: World Health Organization, 2002.
  5. Shim JJ, Park HJ, Kim JW, et al. The Korean national liver cancer surveillance program: experience of a single healthcare center in 2011. Korean J Med 2013;84:672-680. https://doi.org/10.3904/kjm.2013.84.5.672
  6. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022. https://doi.org/10.1002/hep.24199
  7. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943. https://doi.org/10.1016/j.jhep.2011.12.001

Cited by

  1. 간세포암종 치료에 대한 한의 임상 가이드라인 vol.20, pp.1, 2013, https://doi.org/10.15432/jkto.2015.20.1.055